These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20101226)

  • 1. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.
    West NR; Watson PH
    Oncogene; 2010 Apr; 29(14):2083-92. PubMed ID: 20101226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N; Heath JK
    Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A7 (psoriasin) influences immune response genes in human breast cancer.
    Mandal S; Curtis L; Pind M; Murphy LC; Watson PH
    Exp Cell Res; 2007 Aug; 313(14):3016-25. PubMed ID: 17560571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
    Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
    Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M; Richards CD; Gauldie J
    Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
    Carlsson H; Petersson S; Enerbäck C
    Int J Oncol; 2005 Dec; 27(6):1473-81. PubMed ID: 16273201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of oncostatin M receptor beta in metastatic melanoma cells.
    Lacreusette A; Nguyen JM; Pandolfino MC; Khammari A; Dreno B; Jacques Y; Godard A; Blanchard F
    Oncogene; 2007 Feb; 26(6):881-92. PubMed ID: 16909117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
    West NR; Murray JI; Watson PH
    Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
    Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
    Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
    Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.
    Yu SE; Jang YK
    Biochem Biophys Res Commun; 2012 Oct; 427(2):336-42. PubMed ID: 23000163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
    Emberley ED; Niu Y; Njue C; Kliewer EV; Murphy LC; Watson PH
    Clin Cancer Res; 2003 Jul; 9(7):2627-31. PubMed ID: 12855640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.